Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D84KSZ
|
|||
| Drug Name |
XXB750
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Phase 2 | [1] | |
| Heart failure with preserved ejection fraction [ICD-11: BD11.0] | Phase 1 | [2] | ||
| Company |
Novartis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05562934) A Multi-center, Randomized, Double-blind, Parallel-group, 20-week Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of XXB750 in Patients With Resistant Hypertension. U.S.National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT05328752) A Randomized, Participant- and Investigator-blinded, Sponsor Open-label, Placebo-controlled, Single and Multiple Dose Study to Investigate the Safety and Tolerability of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.